Loblaw Companies Limited · TSX:L
Loblaw Companies — Q3 2026 Earnings Presentation
5 slides from Loblaw Companies's earnings presentation, Oct 10, 2026
Slide 1: Supplementary Slides Q3 2026
SUPPLEMENTARY SLIDES Q3 2026 For the periods ended October 10, 2026 and October 4, 2025 1
Slide 2: Forward Looking Statements
FORWARD LOOKING STATEMENTS This presentation for Loblaw Companies Limited (“Loblaw” or “the Company”) contains forward-looking statements about the Company’s objectives, plans, goals, aspirations, strategies, financial condition, results of operations, cash flows, performance, prospects, opportuniti
Slide 3: Key Financial Metrics – Total Company
KEY FINANCIAL METRICS – Total Company(1) Q3 2026 (millions of Canadian dollars unless otherwise noted) Q3 2026 Q3 2025 % Change(2) Adjusted EBITDA $2,250 $2,206 ↑ +2.0% Adjusted income from equity-accounted investments $9 — ↑ +100.0% Adjusted EBITDA Margin 11.3 % 11.4 % ↓ -10 bps Adjusted Net Earnin
Slide 4: Key Financial Metrics – Retail
KEY FINANCIAL METRICS – Retail(1) Q3 2026 (millions of Canadian dollars unless otherwise noted) Q3 2026 Q3 2025 % Change(2) Sales $19,857 $19,160 ↑ +3.6% Sales - Food $14,048 $13,666 Sales - Drug $5,809 $5,494 Pharmacy and Healthcare Services $3,202 $2,953 Front Store $2,607 $2,541 Gross Margin(3) 3
Slide 5: Key Operational Metrics
KEY OPERATIONAL METRICS Q3 2026 Food Retail (Loblaw) % Change(1) Food Retail Same-Store Sales Growth ↑ +0.6% Basket Size(2) ↑ Traffic(2) ↓ Loblaw STM Square Footage Growth ↑ Industry STM Square Footage Growth ↑ Drug Retail (Shoppers Drug Mart) % Change (1) Drug Retail Same-Store Sales Growth ↑ +4.8%